Click on image to view larger version.

Figure 2 Time to first event (death or adjudicated MI or adjudicated recurrent angina) at 30 days (enoxaparin vs. unfractionated heparin [UFH]) (intention-to-treat population, N = 1,224). Censor: marks point at which patients were withdrawn from study without further 30-day follow-up data.